Been hearing this a lot if a peptide is under $100, it’s probably underdosed or low purity. Talking mainly about stuff like BPC-157. You guys think price is a good indicator or just marketing? I’ve seen cheaper options but always wonder if it’s just a gamble at that point.

Exposure without recovery leads to stagnation and regression.

Health markers stable before considering anything

Recovery capacity ultimately limits productive training exposure volume.

Pharmaceutical trends favor general analgesics over targeted relaxants.

Build foundations before adding any support

Patients demand quick relief, not mechanistic explanations usually.

Exposure initiates change, recovery completes adaptation process fully.

Most intermediates grow fine without them

Recovery quality determines long term physique progression sustainability.

Mechanism drugs sometimes slower or less immediately noticeable.

When recovery, diet and sleep dialed

Diagnostic uncertainty makes generalized symptom management safer initially.

Exposure is easy, recovery optimization requires discipline consistently.

Once basics stop limiting progress

Not until training maturity is proven